Workflow
NBS Next growth framework
icon
Search documents
Nordson Corporation Reports Record Fourth Quarter and Fiscal Year 2025 Results
Businesswireยท 2025-12-10 21:30
Core Insights - Nordson Corporation reported a 1% increase in fourth quarter sales for fiscal year 2025, reaching $752 million compared to $744 million in the previous year, influenced by favorable currency translation and acquisition impacts, but offset by a divestiture and organic sales decrease [1][2][4] - The company achieved a record net income of $152 million for the fourth quarter, translating to earnings per diluted share of $2.69, up from $122 million and $2.12 in the prior year [2][9] - Adjusted net income for the fourth quarter was $171 million, a 6.9% increase from $160 million in the previous year, with adjusted earnings per diluted share rising 9% to $3.03 [2][26] Financial Performance - EBITDA for the fourth quarter was $256 million, representing 34% of sales, an increase of 6% from $241 million or 32% of sales in the prior year [3][10] - For the full fiscal year 2025, total sales reached a record $2.8 billion, a 4% increase from the previous year, driven by a favorable acquisition impact of 6% despite a 3% decrease in organic volume [8][9] - Full-year EBITDA was $900 million, maintaining a margin of 32%, consistent with the previous year [10] Segment Performance - Industrial Precision Solutions sales decreased by 2% to $362 million, impacted by a 4% organic sales decline, while EBITDA remained stable at $137 million [5][17] - Medical and Fluid Solutions saw a 10% increase in sales to $220 million, with organic sales growth of 7% and EBITDA rising to $88 million, a margin increase of 380 basis points [6][18] - Advanced Technology Solutions experienced a 4% sales decline to $171 million, with EBITDA decreasing to $43 million, reflecting a margin drop [7][19] Outlook - The company enters fiscal 2026 with a backlog of approximately $600 million, a 5% increase from the prior year [12] - Sales for fiscal 2026 are projected to be between $2.83 billion and $2.95 billion, with adjusted earnings forecasted in the range of $10.80 to $11.50 per diluted share [13][14] - Management expressed optimism for solid growth in 2026, supported by the implementation of the Ascend Strategy and a focus on shareholder value through strategic capital deployment [14]